Document:

EX-10.1

 Exhibit 10.1 

EXECUTION VERSION 

AMENDMENT AGREEMENT 

AMENDMENT AGREEMENT dated as of August 1, 2017 (this “Amendment”) to the Revolving Credit Agreement, dated as of
February 1, 2017 (the “Credit Agreement”), among Walgreens Boots Alliance, Inc., as the Borrower, JPMorgan Chase Bank, N.A., as Administrative Agent, the Lenders from time to time party thereto and each other party
thereto. 
 1. Defined Terms. Capitalized terms used and not otherwise defined herein have the meanings assigned to them in the
Credit Agreement. 
 2. Amendments to the Credit Agreement. Each of the parties hereto agrees that, effective on the Amendment
Effective Date (as defined below) the definition of “Facility Termination Date” included in the Credit Agreement shall be amended by replacing “the date which is 364 days following the Effective Date” with “January 31,
2019”. 
 3. Conditions to Effectiveness. This Amendment shall become effective on the date (the “Amendment
Effective Date”) when: 
 (a) the Administrative Agent shall have received counterparts to this Amendment executed by
(i) the Borrower, (ii) the Administrative Agent and (iii) the Lenders; 
 (b) the Borrower shall have paid to the
Administrative Agent for the account of each Lender party hereto a fee (the “Extension Fee”) in an aggregate amount equal to 0.05% of such Lender’s Commitment, with such Extension Fee to be due and payable upon satisfaction of
the condition set forth in clause (a) above; and 
 (c) (1) no Default or Unmatured Default shall have occurred and be continuing
on or as of the Amendment Effective Date and (2) all representations and warranties of the Borrower set forth in Article 5 of the Credit Agreement shall be true and correct in all material respects (except to the extent such representations and
warranties are qualified with “materiality” or “Material Adverse Effect” or similar terms, in which case such representations and warranties shall be true and correct in all respects) as if made on or as of the Amendment
Effective Date, except to the extent a representation or warranty is stated to relate solely to an earlier date, in which case the representation or warranty shall be true and correct in all material respects (except to the extent such
representations and warranties are qualified with “materiality” or “Material Adverse Effect” or similar terms, in which case such representations and warranties shall be true and correct in all respects) on and as such earlier
date and, by executing this Amendment, the Company hereby certifies that this clause (c) is met as of the Amendment Effective Date. 

4. Ratification. Except to the extent hereby amended, the Credit Agreement and each of the Loan Documents remain in full force and
effect and are hereby ratified and affirmed. 
 5. Indemnities. The Borrower agrees that this Amendment constitutes a Loan Document
and Section 9.06 of the Credit Agreement is hereby incorporated by reference herein and shall extend to the preparation, execution and delivery of this Amendment. 

 6. Limitation. This Amendment shall be limited precisely as written and except as
expressly provided herein, shall not be deemed (a) to be a consent granted pursuant to, or a waiver or modification of, any term or condition of the Credit Agreement or any of the instruments or agreements referred to therein or (b) to
prejudice any right or rights which the Administrative Agent or the Lenders may now have or have in the future under or in connection with the Credit Agreement or any of the instruments or agreements referred to therein. Unless the context indicates
otherwise, on and after the Amendment Effective Date, whenever the Credit Agreement is referred to in the Credit Agreement, the other Loan Documents or any of the instruments, agreements or other documents or papers executed or delivered in
connection therewith, such reference shall be deemed to mean the Credit Agreement as amended by this Amendment. 
 7. Counterparts.
This Amendment may be executed in any number of counterparts and by the different parties hereto in separate counterparts, each of which shall be an original and all of which, when taken together, shall constitute but one and the same instrument. A
facsimile or .pdf copy of a counterpart signature page shall serve as the functional equivalent of a manually executed copy for all purposes. 

8. Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK. 

9. Consent to Jurisdiction; Waiver of Jury Trial. Each of Sections 15.02 and 15.03 of the Credit Agreement are hereby incorporated by
reference herein and shall extend to the preparation, execution and delivery of this Amendment. 
 [SIGNATURE PAGES FOLLOW] 

  
 2 

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed by their
respective authorized officers as of the day and year first above written. 
  

					
	 WALGREENS BOOTS ALLIANCE, INC.
as the Borrower

		
	By:	 	 /s/ Claudio Moreno

		 	Name:	 	Claudio Moreno
		 	Title:	 	Vice President, Global Treasury

 [Walgreens Amendment – Signature Page] 

 
					
	 JPMORGAN CHASE BANK, N.A.
as Administrative Agent and Lender

		
	By:	 	 /s/ Dawn Lee Lum

		 	Name:	 	Dawn Lee Lum
		 	Title:	 	Executive Director

 [Walgreens Amendment – Signature Page] 

 
					
	 MIZUHO BANK, LTD.,
as Lender

		
	By:	 	 /s/ Tracy Rahn

		 	Name:	 	Tracy Rahn
		 	Title:	 	Authorized Signatory

 [Walgreens Amendment – Signature Page] 

 
					
	 THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.,
as Lender

		
	By:	 	 /s/ Mark Maloney

		 	Name:	 	Mark Maloney
		 	Title:	 	Authorized Signatory

 [Walgreens Amendment – Signature Page] 

 
					
	 U.S. BANK NATIONAL ASSOCIATION,
as Lender

		
	By:	 	 /s/ Conan Schleicher

		 	Name:	 	Conan Schleicher
		 	Title:	 	Senior Vice President

 [Walgreens Amendment – Signature Page]Exhibit

Exhibit 10.4
Corporate Policy
NASDAQ, INC.
BOARD COMPENSATION POLICY
AMENDED AND RESTATED ON MAY 10, 2017
PURPOSE & STATEMENT OF POLICY
	
			
	Annual Non-Employee Director (“Director”) compensation consists of the following elements, each of which is discussed further below: (i) annual retainer, (ii) annual equity award, (iii) annual committee chair fees (for certain committees) and (v) annual committee member fees (for certain committees).

	 
	QUESTIONS?
Please contact the Stock Plan Administrator if at any time you have questions about the equity element of the policy.  Please contact the Office of the Corporate Secretary with questions about the cash element of the policy.

	Director compensation will be based on a compensation year in connection with the annual meeting of stockholders (the “Annual Meeting”). This enables Directors to receive equity immediately following election and appointment to the Board at the Annual Meeting.
	 

APPLICABILITY & SCOPE
This Policy is applicable to all non-employee Directors of Nasdaq, Inc. 
ANNUAL RETAINER
+    Annual Director Retainer compensation is equal to a total value of 75,000 for each Director, other than the Chairman of the Board. 
+    The Lead Independent Director will receive the Director Retainer plus an additional Lead Independent Director Retainer of $75,000 for the period of time from January 1, 2017 through the 2017 Annual Meeting of Stockholders.
+     The Chairman of the Board will receive Chairman Retainer compensation equal to a total value of $240,000.
+    The Annual Retainer will be delivered in the form of equity; however, Directors may annually elect to receive the Annual Retainer compensation in cash or equity. Each Director will have the opportunity to make this election during the thirty (30) day period preceding the Annual Meeting. If the Director declines to make an election, the entire Annual Retainer will be paid in equity.

+    Equity will be issued as Restricted Stock Units to each eligible director automatically on the date of the Annual Meeting immediately following the Director’s election and appointment by the Board. The equity portion selected will be paid in accordance with the “Policies and Procedures Relating to Equity Grants” below.   
+    If cash is selected, the cash portion will be paid semi-annually in arrears, in equal installments, no later than the fifteenth day of the third month following the end of the semi-annual period; provided, however, that a Director will have a right to receive a cash payment for any given period only if that person serves as a Director during all or a portion of that period, with the cash payment for the period being prorated in the case of a person who serves as a Director during only a portion of a period (other than on account of death or disability).  
+    A Director appointed after the annual shareholders meeting will be eligible to receive a prorated share of the Annual Retainer compensation. Such a Director may elect to receive the Annual Retainer compensation in cash or equity.  Equity will be paid retroactively on the date of the next Annual Meeting. Any cash portion will be paid semi-annually in arrears. 

ANNUAL EQUITY AWARD
+    All Directors, including the Chairman and Lead Independent Director, will receive an additional annual equity award in the form of Restricted Stock Units, in the amount of $200,000 per annum.

+    The annual equity award will be granted to each Director automatically on the date of the Annual Meeting immediately following the Director’s election and appointment to the Board.

+    The annual equity award will be paid in accordance with the “Policies and Procedures Relating to Equity Grants” below.

ANNUAL COMMITTEE CHAIR FEES 
+    The Chairperson of each of the Audit and Management Compensation Committees will receive an Annual Chair Fee of $30,000.

+    The Chairperson of the Finance and Nominating & Governance Committees will receive an Annual Chair Fee of $20,000.

+    The Annual Chair fees will be paid in equity; however, each Chairperson may elect to receive the Annual Chair fees in cash. The Annual Chair fees will be issued as Restricted Stock Units to each eligible director automatically on the date of the Annual Meeting immediately following the Director’s election and appointment by the Board.  Fees paid in equity will be paid in accordance with the “Policies and Procedures Relating to Equity Grants” below. 

+    If cash is selected, the cash portion will be paid semi-annually in arrears, in equal installments, no later than the fifteenth day of the third month following the end of the semi-annual period; provided, however, that a Director will have a right to receive a cash payment for any given period only if that person serves as a Director during all or a portion of that period, with the cash payment for the period being prorated in the case of a person who serves as a Director during only a portion of a period (other than on account of death or disability). 

ANNUAL COMMITTEE MEMBER FEES 
+    Each Non-Chair Member of the Audit and Management Compensation Committees will receive an annual membership fee of $10,000.

Each Non-Chair Member of the Finance and Nominating & Governance Committees will receive an annual membership fee of $5,000.

+    The Annual Committee Member fees will be paid in equity; however, each Non-Chair Member may elect to receive the Annual Committee Member fees in cash.  The Annual Committee Member fees will be issued as Restricted Stock Units to each eligible director automatically on the date of the Annual Meeting immediately following the Director’s election and appointment by the Board.  Fees paid in equity will be paid in accordance with the “Policies and Procedures Relating to Equity Grants” below. 

+    If cash is selected, the cash portion will be paid semi-annually in arrears, in equal installments, no later than the fifteenth day of the third month following the end of the semi-annual period; provided, however, that a Director will have a right to receive a cash payment for any given period only if that person serves as a Director during all 

NASDAQ BOARD COMPENSATION PROGRAM    |  2

or a portion of that period, with the cash payment for the period being prorated in the case of a person who serves as a Director during only a portion of a period (other than on account of death or disability) 

POLICIES AND PROCEDURES RELATING TO EQUITY GRANTS
GENERAL

+    All Director equity will be granted under the Equity Plan.
+    Calculation of the number of shares of equity to be awarded to Directors will be valued at 100% of face value and based on the closing price of Nasdaq’s common stock on the date of the grant. Equity awards are non-transferable and must be issued to the Director.   
VESTING
+    Equity awards will vest 100% one (1) year from the date of the grant. Equity awards will also vest upon the scheduled expiration of a Director’s term, if such term is not renewed.
+    Upon a Director’s resignation (other than for death or disability) prior to the end of the Director’s term, equity awards will be forfeited.
+    Upon termination of a Director for “Misconduct,” all equity awards will be forfeited without further consideration to the Director.
+    Upon termination of a Director on account of his death or disability, equity awards will vest.
+    Shortly after vesting, vested shares will appear in the Director’s account at E*Trade. To view this information, a Director may log directly onto his or her online E*Trade account at https://us.etrade.com/e/t/user/login_sp. Additionally, a Director may contact E*Trade’s Executive Services Team at 1.866.987.2339 or via email at executiveservices@etrade.com
EQUITY AGREEMENTS, SHARE RESTRICTIONS & VOTING RIGHTS
+    Equity awards will be evidenced by an Equity Award Agreement to be entered into with each Director.
+    Once vested, shares will be freely tradeable. Nasdaq does not have a repurchase right or obligation.
+    Trading in Nasdaq shares, however, is subject to the Director and Executive Officers Trading Policy and to any contractual restrictions on transfer, such as lock-up agreements, that may be applicable.
REPORTING AND DISCLOSURE
+    SEC Form 4s (Change in Beneficial Ownership) must be filed by each Director with the SEC within 2 business days of equity grants.  The Director may request Nasdaq’s assistance with the preparation and filing of Form 4s and other Section 16 reports by providing a completed Power of Attorney and CIK/CCC Code, if the Director has a CIK/CCC Code currently assigned.
+    Equity will be reflected as stock owned by Directors, if required, in the Beneficial Ownership Table of the Nasdaq Proxy and will be disclosed under the general Director Compensation section of the Proxy.
STOCK OWNERSHIP GUIDELINES FOR DIRECTORS
+    Stock ownership guidelines for Directors of Nasdaq are as follows.

NASDAQ BOARD COMPENSATION PROGRAM    |  3

Value of Shares Owned
5x annual cash retainer
+    New Directors are expected to meet the applicable level of ownership within four years of their election to the Board of Directors.
+    The value of shares owned will be calculated based upon Nasdaq’s average closing common stock price for a 90 day period prior to the date on which the Director is expected to meet the applicable level of stock ownership.
+    Shares that count toward meeting the stock ownership guidelines include:
		
	þ
	Shares owned outright (e.g., shares obtained upon option exercise, shares purchased in the open market, etc.)

		
	þ
	Shared ownership (e.g., shares owned or held in trust by immediate family)

		
	þ
	Vested and unvested restricted shares

+    Shares that do not count toward meeting the stock ownership guidelines:
		
	þ
	Vested stock options

		
	þ
	Unvested stock options

+    Once an applicable guideline threshold has been attained, the Director is expected to continuously retain sufficient share ownership to meet the guideline for as long as the Director is subject to the Stock Ownership Guidelines.
+    There may be instances where an exception to the guidelines is necessary or appropriate, including in cases where the satisfaction of the guidelines would place a severe hardship on the Director. In such cases, the Chairman of the Board will make a final determination as to whether an exception to the Stock Ownership Guidelines, in whole or in part, will be granted.
 

NASDAQ BOARD COMPENSATION PROGRAM    |  4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00273-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00273-of-00352.parquet"}]]